189 related articles for article (PubMed ID: 3119545)
1. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
[TBL] [Abstract][Full Text] [Related]
2. DNA breaks and repair in the mouse leukemia L1210 cells exposed to three different types of interstrand DNA cross-linkers.
Yajima N; Hochi S; Miyata N; Kishi T; Kawanishi G
Mutat Res; 1990 Jul; 236(1):43-50. PubMed ID: 2114540
[TBL] [Abstract][Full Text] [Related]
3. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
4. Antitumor mechanisms of zinostatin stimalamer (YM881).
Tanaka S; Yamamoto M; Numasaki Y
Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
[TBL] [Abstract][Full Text] [Related]
5. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
[No Abstract] [Full Text] [Related]
7. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553
[TBL] [Abstract][Full Text] [Related]
8. Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells.
Masuda K; Nakamura T; Mizota T; Mori J; Shimomura K
Cancer Res; 1988 Sep; 48(18):5172-7. PubMed ID: 3409243
[TBL] [Abstract][Full Text] [Related]
9. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
[TBL] [Abstract][Full Text] [Related]
10. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival.
Bhuyan BK; Newell KA; Crampton SL; Von Hoff DD
Cancer Res; 1982 Sep; 42(9):3532-7. PubMed ID: 7105029
[TBL] [Abstract][Full Text] [Related]
11. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
12. Effects of chartreusin on cell survival and cell cycle progression.
Bhuyan BK; Robinson MI; Shugars KD; Bono VH; Dion RL
Cancer Res; 1978 Sep; 38(9):2734-9. PubMed ID: 567096
[TBL] [Abstract][Full Text] [Related]
13. Aclarubicin inhibits etoposide induced apoptosis through inhibition of RNA synthesis in P388 murine leukemic cells.
Nagata T; Higashigawa M; Shimono Y; Cao DC; Yan Mao X; M'soka T; Inamochi H; Hori H; Kawasaki H; Sakurai M
J Exp Clin Cancer Res; 1998 Dec; 17(4):435-42. PubMed ID: 10089064
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
[TBL] [Abstract][Full Text] [Related]
15. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
Li ZR; Feng JB; Liang F; Zeng SX; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
[No Abstract] [Full Text] [Related]
16. Mechanism of action of tetra-mu-carboxylatodirhodium(II) in L1210 tumor suspension culture.
Howard RA; Kimball AP; Bear JL
Cancer Res; 1979 Jul; 39(7 Pt 1):2568-73. PubMed ID: 445459
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle effects of CC-1065.
Bhuyan BK; Crampton SL; Adams EG
Cancer Res; 1983 Sep; 43(9):4227-32. PubMed ID: 6871861
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the mechanism of action of busulfan with hepsulfam, a new antileukemic agent, in the L1210 cell line.
Pacheco DY; Stratton NK; Gibson NW
Cancer Res; 1989 Sep; 49(18):5108-10. PubMed ID: 2766282
[TBL] [Abstract][Full Text] [Related]
19. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
[TBL] [Abstract][Full Text] [Related]
20. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
